Your browser doesn't support javascript.
loading
Cellular immunotherapy in multiple myeloma.
Vo, Manh-Cuong; Lakshmi, Thangaraj Jaya; Jung, Sung-Hoon; Cho, Duck; Park, Hye-Seong; Chu, Tan-Huy; Lee, Hyun-Ju; Kim, Hyeoung-Joon; Kim, Sang-Ki; Lee, Je-Jung.
Afiliación
  • Vo MC; Research Center for Cancer Immunotherapy, Chonnam National University Hwasun Hospital, Hwasun, Korea.
  • Lakshmi TJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Korea.
  • Jung SH; Research Center for Cancer Immunotherapy, Chonnam National University Hwasun Hospital, Hwasun, Korea.
  • Cho D; Research Center for Cancer Immunotherapy, Chonnam National University Hwasun Hospital, Hwasun, Korea.
  • Park HS; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Korea.
  • Chu TH; Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Lee HJ; Research Center for Cancer Immunotherapy, Chonnam National University Hwasun Hospital, Hwasun, Korea.
  • Kim HJ; Research Center for Cancer Immunotherapy, Chonnam National University Hwasun Hospital, Hwasun, Korea.
  • Kim SK; VaxCell-Bio Therapeutics, Hwasun, College of Industrial Science, Kongju National University, Yesan, Korea.
  • Lee JJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Korea.
Korean J Intern Med ; 34(5): 954-965, 2019 Sep.
Article en En | MEDLINE | ID: mdl-30754964
In multiple myeloma (MM), the impaired function of several types of immune cells favors the tumor's escape from immune surveillance and, therefore, its growth and survival. Tremendous improvements have been made in the treatment of MM over the past decade but cellular immunotherapy using dendritic cells, natural killer cells, and genetically engineered T-cells represent a new therapeutic era. The application of these treatments is growing rapidly, based on their capacity to eradicate MM. In this review, we summarize recent progress in cellular immunotherapy for MM and its future prospects.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Vacunas contra el Cáncer / Antineoplásicos Inmunológicos / Mieloma Múltiple Límite: Animals / Humans Idioma: En Revista: Korean J Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2019 Tipo del documento: Article Pais de publicación: Corea del Sur
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Vacunas contra el Cáncer / Antineoplásicos Inmunológicos / Mieloma Múltiple Límite: Animals / Humans Idioma: En Revista: Korean J Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2019 Tipo del documento: Article Pais de publicación: Corea del Sur